Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
Clinical trial NCT03825367 · UNKNOWN
Trial details
- NCT number
- NCT03825367
- Sponsor
- Therapeutic Advances in Childhood Leukemia Consortium
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-29
- Primary completion
- 2023-05-31
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.